Silver Book Fact

An experimental drug has been found to extend the lives of kidney patients by about 3.5 months–from 7 to just under 11. It has also been shown to delay tumor growth. Patients lived a median of 3.7 months before their tumors got worse–as opposed to 1.9 months.

Szabo, Liz. New Weapons Do Battle with Kidney Cancer. USA Today. June 4 2006. http://www.usatoday.com/news/health/2006-06-04-kidney-cancer_x.htm?csp=34

Reference

Title
New Weapons Do Battle with Kidney Cancer
Publication
USA Today
Publication Date
June 4 2006
Authors
Szabo, Liz
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Use of the Pap smear test is credited with cutting the age-adjusted cervical cancer incidence in half between 1975 and 2001, reducing it from 14.8 to 7.9 cases per 100,000…  
  • Approximately one third of men diagnosed with prostate cancer will opt for surgical treatment.  
  • According to the Pharmaceutical Research and Manufacturers of America, a cancer medicine in the pipeline would inhibit production of a protein that may interfere with the effectiveness of chemotherapy.  
  • According to the Pharmaceutical Research and Manufacturers of America, a medicine currently in development may delay the worsening of liver cancer. The medicine is an oral signal transduction inhibitor…  
  • When detected early, the 5-year survival rate for colorectal cancer is 90%; however, only 39% of colorectal cancers are diagnosed early, mainly because of low rates of screening.